Original Research

Emodin Reverses Gemcitabine Resistance of Pancreatic Cancer Cell Lines Through Inhibition of IKKβ/NF-κB Signaling Pathway

Tong H, Huang Z, Chen H, Zhou B, Liao Y, Wang Z

OncoTargets and Therapy 2020, 13:9839-9848

Published Date: 2 October 2020